SCHEMBL19230596

SCHEMBL19230596

COC(=O)c1ccc2c(c1)CN(c1ccc(O)cc1Cl)C2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 1/20 0.49
▸ PDK2 Q15119 1/20 0.49
▸ PDK3 Q15120 1/20 0.49
▸ PDK4 Q16654 1/20 0.49
▸ WDR5 P61964 3/20 0.47
▸ NPC1 O15118 4/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ CA14 Q9ULX7 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19230583 0.92 PDK1 (0.49) PDK1PDK2PDK3PDK4WDR5
SCHEMBL19230510 0.86 WDR5 (0.49) WDR5NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL19230514 0.84 PDK1 (0.46) PDK1PDK2PDK3PDK4KDM4E
SCHEMBL19230594 0.82 PDK1 (0.44) PDK1PDK2PDK3PDK4NPC1
SCHEMBL19284492 0.80 CA12 (0.53) PDK1PDK2PDK3PDK4NPC1
SCHEMBL19230582 0.76 PDK1 (0.46) PDK1PDK2PDK3PDK4KDM4E
SCHEMBL19284497 0.76 ALDH1A1 (0.49) PDK1PDK2PDK3PDK4NPC1
SCHEMBL12922780 0.75 NAMPT (0.49) NPC1RAB9AKDM4ESMN1; SMN2NPSR1
SCHEMBL19230513 0.75 KDM4E (0.48) KDM4EALDH1A1CA1CA2CA7
SCHEMBL29715895 0.73 NAMPT (0.50) KDM4ESMN1; SMN2ALDH1A1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108602811-B FXR receptor agonists 轩竹生物科技有限公司 2021-11-16 — — CN disclosed
WO-2017147047-A1 FXR MODULATORS AND METHODS OF THEIR USE ALIOS BIOPHARMA, INC. (US) 2017-08-31 — — WO disclosed
WO-2017147047-A1 FXR MODULATORS AND METHODS OF THEIR USE ALIOS BIOPHARMA, INC. (US) 2017-08-31 — — WO disclosed
WO-2017133521-A1 FXR RECEPTOR AGONIST 山东轩竹医药科技有限公司 2017-08-10 — — WO disclosed
Send feedback